PharmaCyte Biotech Successfully Completes Second Container Closure Integrity Test

LAGUNA HILLS, Calif.–(BUSINESS WIRE)– #INDstatus–PharmaCyte Biotech successfully completes its second Contain Closure Integrity test on its clinical trial product for its pancreatic cancer therapy.